ATE328607T1 - Von membran-proteoliposomen patient-spezifischen bösartigen weissen blutzellen impstoff - Google Patents
Von membran-proteoliposomen patient-spezifischen bösartigen weissen blutzellen impstoffInfo
- Publication number
- ATE328607T1 ATE328607T1 AT99900822T AT99900822T ATE328607T1 AT E328607 T1 ATE328607 T1 AT E328607T1 AT 99900822 T AT99900822 T AT 99900822T AT 99900822 T AT99900822 T AT 99900822T AT E328607 T1 ATE328607 T1 AT E328607T1
- Authority
- AT
- Austria
- Prior art keywords
- patient
- specific
- blood cell
- white blood
- membrane
- Prior art date
Links
- 210000000265 leukocyte Anatomy 0.000 title abstract 4
- 239000012528 membrane Substances 0.000 title abstract 2
- 239000003725 proteoliposome Substances 0.000 title abstract 2
- 229940030156 cell vaccine Drugs 0.000 title 1
- 230000003211 malignant effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000036210 malignancy Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7170298P | 1998-01-16 | 1998-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328607T1 true ATE328607T1 (de) | 2006-06-15 |
Family
ID=22103016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99900822T ATE328607T1 (de) | 1998-01-16 | 1999-01-15 | Von membran-proteoliposomen patient-spezifischen bösartigen weissen blutzellen impstoff |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6207170B1 (de) |
| EP (1) | EP1045698B1 (de) |
| JP (1) | JP2002509114A (de) |
| AT (1) | ATE328607T1 (de) |
| AU (1) | AU737330B2 (de) |
| CA (1) | CA2318557A1 (de) |
| DE (1) | DE69931749T2 (de) |
| WO (1) | WO1999036085A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ755300A0 (en) * | 2000-05-17 | 2000-06-08 | Monash University | Immune potentiating compositions |
| PE20020572A1 (es) * | 2000-12-06 | 2002-07-31 | Centro Inmunologia Molecular | Preparaciones para potenciar la inmunogenicidad de antigenos poco inmunogenicos |
| WO2008005859A2 (en) * | 2006-06-30 | 2008-01-10 | Baylor Research Institute | Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells |
| FR3025107B1 (fr) | 2014-08-29 | 2018-10-05 | Calixar | Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations |
| US10107791B2 (en) * | 2015-12-01 | 2018-10-23 | Purdue Research Foundation | Proteoliposome and production method thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816249A (en) | 1981-11-17 | 1989-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Monoclonal anti-idiotype antibodies |
| IT1206250B (it) | 1987-02-18 | 1989-04-14 | Ist Farmacoterapico It Spa | Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla- |
| US5194384A (en) | 1987-04-23 | 1993-03-16 | Bystryn Jean Claude | Method for preparing human meloma vaccine |
| US5030621A (en) | 1987-04-23 | 1991-07-09 | Bystryn Jean Claude | Shed melanoma antigen compositions |
| AU5361794A (en) | 1992-10-14 | 1994-05-09 | Board Of Trustees Of The Leland Stanford Junior University | Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates |
| US6077519A (en) * | 1993-01-29 | 2000-06-20 | University Of Pittsburgh | Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients |
| CA2246708C (en) * | 1996-02-16 | 2005-06-14 | Biomira Usa Inc. | Vaccine for b-cell malignancies |
-
1999
- 1999-01-15 EP EP99900822A patent/EP1045698B1/de not_active Expired - Lifetime
- 1999-01-15 JP JP2000539858A patent/JP2002509114A/ja active Pending
- 1999-01-15 DE DE69931749T patent/DE69931749T2/de not_active Expired - Fee Related
- 1999-01-15 WO PCT/US1999/000935 patent/WO1999036085A1/en active IP Right Grant
- 1999-01-15 AT AT99900822T patent/ATE328607T1/de not_active IP Right Cessation
- 1999-01-15 US US09/231,650 patent/US6207170B1/en not_active Expired - Fee Related
- 1999-01-15 AU AU20318/99A patent/AU737330B2/en not_active Ceased
- 1999-01-15 CA CA002318557A patent/CA2318557A1/en not_active Abandoned
-
2001
- 2001-03-26 US US09/816,266 patent/US20010012517A1/en not_active Abandoned
-
2002
- 2002-04-12 US US10/120,450 patent/US20020155135A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1045698A1 (de) | 2000-10-25 |
| US20020155135A1 (en) | 2002-10-24 |
| CA2318557A1 (en) | 1999-07-22 |
| AU2031899A (en) | 1999-08-02 |
| DE69931749D1 (de) | 2006-07-20 |
| US6207170B1 (en) | 2001-03-27 |
| WO1999036085A1 (en) | 1999-07-22 |
| AU737330B2 (en) | 2001-08-16 |
| US20010012517A1 (en) | 2001-08-09 |
| DE69931749T2 (de) | 2007-05-31 |
| EP1045698B1 (de) | 2006-06-07 |
| JP2002509114A (ja) | 2002-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX161924A (es) | Mejoras en diafragma para bombas y similares | |
| ATE329672T1 (de) | Hämodiafiltration/hämofiltrations-patronen | |
| DE69005347T2 (de) | Absaugkanüle für chirurgische Zwecke, insbesondere für Fettabsaugung. | |
| EP0727438A3 (de) | PEG und GM-CSF Addukte | |
| ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
| DE69732049D1 (de) | Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika | |
| NO20040965L (no) | Blandinger og fremgangsmater for priming av monocyttiske dendrittiske celler og T-celler i TH-1-respons. | |
| ATE273386T1 (de) | Menschliches cyclin e | |
| DK0783297T3 (da) | Polyethylenglycol-modificerede ceramid-lipider og liposomer | |
| EA199800272A1 (ru) | Фактор, стимулирующий дендритные клетки | |
| DE68909909T2 (de) | Vorrichtung zur Herstellung von zusammengehefteten Sätzen von Dokumenten im Hoch- und Querformat. | |
| ATE328607T1 (de) | Von membran-proteoliposomen patient-spezifischen bösartigen weissen blutzellen impstoff | |
| ATE380202T1 (de) | Interaktionssystem zur präsentation und entfernung von substanzen | |
| PT1131408E (pt) | Acidos oligossacarido-aldonicos e sua utilizacao topica | |
| ATE247981T1 (de) | Proteinenthaltende pharmazeutische zubereitung | |
| NO883834L (no) | Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids. | |
| DE68914571D1 (de) | Elektroeinsetzung von Proteinen in Membranen von Tierzellen. | |
| DE68910577D1 (de) | Mittel gegen den AIDS-Virus. | |
| DE69528170D1 (de) | Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen | |
| FI953534A (fi) | Menetelmä sellaisten yksölöiden tunnistamiseksi ja hoitamiseksi, joilla on HLA-C-klooni 10/MAGE-1:tä ekspressoivia syöpäsoluja | |
| DE3887732D1 (de) | Gehäuse zur Aufnahme von elektrischen Baugruppen. | |
| EP1601687A4 (de) | Verfahren zur erhöhung der ausbreitung von b-zellen | |
| DE68916969T2 (de) | Prüfung von elektrischen kreisen. | |
| DE60130634D1 (de) | Identifizierung von antigenen peptiden durch zytotoxische t-lymphozyten aktiviert von dendritischen zellhybriden | |
| ATE88350T1 (de) | Arzneimittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1045698 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |